Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Current Assets: 2009-2025

Historic Current Assets for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to $79.2 million.

  • Aytu Biopharma's Current Assets rose 33.54% to $81.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year increase of 33.54%. This contributed to the annual value of $79.2 million for FY2025, which is 27.93% up from last year.
  • Per Aytu Biopharma's latest filing, its Current Assets stood at $79.2 million for FY2025, which was up 27.93% from $61.9 million recorded in FY2024.
  • Aytu Biopharma's 5-year Current Assets high stood at $105.2 million for FY2021, and its period low was $59.9 million during FY2022.
  • Moreover, its 3-year median value for Current Assets was $72.8 million (2023), whereas its average is $71.3 million.
  • In the last 5 years, Aytu Biopharma's Current Assets skyrocketed by 39.53% in 2021 and then plummeted by 43.05% in 2022.
  • Aytu Biopharma's Current Assets (Yearly) stood at $105.2 million in 2021, then tumbled by 43.05% to $59.9 million in 2022, then increased by 21.53% to $72.8 million in 2023, then fell by 15.02% to $61.9 million in 2024, then rose by 27.93% to $79.2 million in 2025.